You are currently viewing archive.bio.org. Head to our home page to check out our fresh new look!

BIO InvestorForum Spotlights Biotech Companies Poised for Growth

WASHINGTON, D.C. (September 8, 2005) — Media registration is now open for BIO InvestorForum 2005, Oct. 18-20 in San Francisco at The Palace Hotel. Organized by the Biotechnology Industry Organization (BIO), BIO InvestorForum 2005 will focus on the biotechnology companies, clinical development areas and research programs that are considered to be investor growth areas.

“This conference is the best opportunity this fall for biotechnology journalists to meet industry leaders, including CEOs, clinical investigators and financial experts, and discover the trends that will shape the biotechnology industry in the coming year,” said Morrie Ruffin, BIO’s Executive Vice President, Capital Formation Section and Business Development.

The BIO InvestorForum 2005 will feature select company presentations, dynamic panel discussions and keynote speeches on such topics as clinical strategy, product development and the shifting regulatory landscape. Discussion will center on growth potential for both public and private companies, as well as the areas most likely to be considered for the “growth watch list” in 2006. In attendance will be institutional investors, venture and private equity investors, as well as research analysts and bankers representing leading banks in the sector.

A series of Therapeutic Workshops and CEO Roundtables will explore hot topics and debate the growth challenges facing the industry. Therapeutic topics include:


  • Developing New Pain Therapeutics in the Post-Vioxx World

  • Clinical Development and Regulatory Trends in the Era of Targeted Cancer Therapies

  • Cancer Genome Sequencing Project, Part 1: Implications for Sequencing Technology

  • Sleeping Giant: Opportunities in Sleep Disorders

  • New Strategies and New Hope in Lupus

  • Cardiovascular Disease: Not for the Faint-Hearted

The slate of CEO Roundtable sessions was developed based on popular demand and includes:


  • Tales from the Trenches: Getting Through an IPO and Thriving in the Aftermarket
    Demystifying Hedge Funds
    Increasing Valuation Through Milestone-Driven Development Strategy and Strategic Outsourcing

  • New Fundraising Strategies and Case Studies in the Current Public Financing Environment

  • The Last Word on the Watch List for 2006: The Buyside Versus Investigator View of Events that Will Shape 2006

Full conference details and online registration are available at www.bio.org. The hosts of the BIO InvestorForum 2005 are Bank of America and Lehman Brothers. Co-hosts are CIBC World Markets, Jefferies, and RBC Capital Markets. Supporting Partners are BayBio, BIOCOM and BIOTECanada.

About BIO

BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products.